Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 15.84% is 61% below its 5-year average of 40.30%, near the low end of its 5-year range (15.84%–49.42%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.83% below its 12-month average of 21.35%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 15.84%.
DEBT TO ASSETS RATIO
15.84%
DEBT TO ASSETS RATIO AVG TTM
21.35%
DEBT TO ASSETS RATIO AVG 3Y
30.79%
DEBT TO ASSETS RATIO AVG 5Y
40.30%
DEBT TO ASSETS RATIO AVG 10Y
40.98%
DEBT TO ASSETS RATIO AVG 15Y
80.22%
DEBT TO ASSETS RATIO AVG 20Y
53.97%
CURRENT VS TTM AVG
-25.83%
CURRENT VS 3Y AVG
-48.56%
CURRENT VS 5Y AVG
-60.70%
CURRENT VS 10Y AVG
-61.35%
CURRENT VS 15Y AVG
-80.26%
CURRENT VS 20Y AVG
-70.66%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+15736.77%
vs the sector median at left
Innoviva, Inc.
Market Cap
$1.53B
Debt to Assets Ratio
15.84%
TTM Avg
21.35%
3Y Avg
30.79%
5Y Avg
40.30%
Market Cap
$1.51B
Debt to Assets Ratio
0.25%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.48B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.47B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | $1.53B | 15.84% | 21.35% | 30.79% | 40.30% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 0.25% | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.50B | 0.00% | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.48B | 0.11% | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.58B | 0.21% | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 0.02% | N/A | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.43B | 0.85% | N/A | N/A | N/A |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 0.22% | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | 0.76% | N/A | N/A | N/A |
Debt/Assets
15.8%
Debt/Equity
0.22
Current Ratio
16.01
Interest Coverage
9.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 15.84% |
| 2026-03-31 | 18.05% |
| 2025-12-31 | 16.45% |
| 2025-09-30 | 22.62% |
| 2025-06-30 | 33.81% |
| 2025-03-31 | 35.97% |
| 2024-12-31 | 34.67% |
| 2024-09-30 | 36.61% |
| 2024-06-30 | 36.80% |
| 2024-03-31 | 35.45% |
| 2023-12-31 | 36.11% |
| 2023-09-30 | 37.78% |
| 2023-06-30 | 40.09% |
| 2023-03-31 | 39.66% |
| 2022-12-31 | 44.18% |
| 2022-09-30 | 40.95% |
| 2022-06-30 | 47.73% |
| 2022-03-31 | 49.00% |
| 2021-12-31 | 42.61% |
| 2021-09-30 | 44.22% |
| 2021-06-30 | 49.42% |
| 2021-03-31 | 35.63% |
| 2020-12-31 | 38.57% |
| 2020-09-30 | 41.57% |
| 2020-06-30 | 43.34% |
| 2020-03-31 | 48.12% |
| 2019-12-31 | 52.03% |
| 2019-09-30 | 57.50% |
| 2019-06-30 | 60.20% |
| 2019-03-31 | 65.46% |
| 2018-12-31 | 69.84% |
| 2018-09-30 | 137.20% |
| 2018-06-30 | 143.65% |
| 2018-03-31 | 175.10% |
| 2017-12-31 | 163.16% |
| 2017-09-30 | 154.35% |
| 2017-06-30 | 175.77% |
| 2017-03-31 | 180.93% |
| 2016-12-31 | 188.94% |
| 2016-09-30 | 195.12% |
| 2016-06-30 | 191.89% |
| 2016-03-31 | 189.39% |
| 2015-12-31 | 172.88% |
| 2015-09-30 | 170.03% |
| 2015-06-30 | 159.81% |
| 2015-03-31 | 149.80% |
| 2014-12-31 | 139.10% |
| 2014-09-30 | 127.34% |
| 2014-06-30 | 121.78% |
| 2014-03-31 | 47.52% |
| 2013-12-31 | 42.20% |
| 2013-09-30 | 43.17% |
| 2013-06-30 | 77.34% |
| 2013-03-31 | 77.77% |
| 2012-12-31 | 46.80% |
| 2012-09-30 | 44.93% |
| 2012-06-30 | 43.19% |
| 2012-03-31 | 79.23% |
| 2011-12-31 | 66.69% |
| 2011-09-30 | 60.92% |
| 2011-06-30 | 56.96% |
| 2011-03-31 | 54.81% |
| 2010-12-31 | 52.17% |
| 2010-09-30 | 81.29% |
| 2010-06-30 | 74.37% |
| 2010-03-31 | 69.18% |
| 2009-12-31 | 95.35% |
| 2009-09-30 | 94.29% |
| 2009-06-30 | 83.96% |
| 2009-03-31 | 80.50% |
| 2008-12-31 | 73.23% |
| 2008-09-30 | 67.76% |
| 2008-06-30 | 61.48% |
| 2008-03-31 | 57.76% |
| 2007-12-31 | 0.33% |
| 2007-09-30 | 0.28% |
| 2007-06-30 | 0.28% |
| 2007-03-31 | 0.24% |
| 2006-12-31 | 0.24% |
| 2006-09-30 | 0.38% |
| 2006-06-30 | 0.40% |
| 2006-03-31 | 0.49% |
| 2005-12-31 | 0.83% |
| 2005-09-30 | 1.10% |
| 2005-06-30 | 1.07% |
| 2005-03-31 | 1.24% |
| 2004-12-31 | 1.54% |
| 2004-09-30 | 2.64% |
| 2004-06-30 | 2.83% |
